Sign In
Buy BMY
$54.72
+0.260 (+0.477%)
At Close: Jun 03, 2026
PFE vs BMY: Which Large Oncology Drugmaker Is a Better Pick Now?
03:45pm, Monday, 16'th Mar 2026
Pfizer and Bristol Myers are racing to strengthen oncology portfolios through deals, new drugs and pipelines ??? investors are weighing which stock stands out.
California Public Employees Retirement System Cuts Stock Position in Bristol Myers Squibb Company $BMY
05:08am, Monday, 16'th Mar 2026
California Public Employees Retirement System trimmed its stake in shares of Bristol Myers Squibb Company (NYSE: BMY) by 8.7% during the undefined quarter, according to the company in its most recent
Ameriprise Financial Inc. Has $1.46 Billion Stock Holdings in Bristol Myers Squibb Company $BMY
04:48am, Sunday, 15'th Mar 2026
Ameriprise Financial Inc. trimmed its holdings in Bristol Myers Squibb Company (NYSE: BMY) by 0.3% in the undefined quarter, according to its most recent disclosure with the Securities and Exchange Co
44 Wealth Management LLC Raises Holdings in Bristol Myers Squibb Company $BMY
03:15am, Sunday, 15'th Mar 2026
44 Wealth Management LLC lifted its position in shares of Bristol Myers Squibb Company (NYSE: BMY) by 16.2% in the undefined quarter, according to its most recent 13F filing with the SEC. The firm own
Glenmede Investment Management LP Purchases 252,666 Shares of Bristol Myers Squibb Company $BMY
05:00am, Saturday, 14'th Mar 2026
Glenmede Investment Management LP grew its position in Bristol Myers Squibb Company (NYSE: BMY) by 31.1% in the third quarter, according to its most recent 13F filing with the Securities and Exchange
Is Bristol Myers' Deep Pipeline the Key to Future Growth?
01:16pm, Thursday, 12'th Mar 2026
BMY highlights a deep pipeline with multiple late-stage candidates and registrational data expected in 2026, reinforcing confidence in its next-gen CELMoD program.
Bristol Myers Squibb Company $BMY Shares Sold by Capital Group Private Client Services Inc.
04:56am, Wednesday, 11'th Mar 2026
Capital Group Private Client Services Inc. decreased its holdings in Bristol Myers Squibb Company (NYSE: BMY) by 89.7% in the undefined quarter, according to the company in its most recent Form 13F fi
BMY Advances CELMoD Program With Positive Phase III Results
10:56am, Tuesday, 10'th Mar 2026
BMY reports positive phase III SUCCESSOR-2 data as mezigdomide combo improves progression-free survival in relapsed multiple myeloma, boosting CELMoD program.
3 Healthcare Stocks Paying the Highest Dividends of 2026
08:45am, Tuesday, 10'th Mar 2026
A handful of the industry's income-generating gems are hiding in plain sight.
Virtus Large Cap Growth SMA Q4 2025 Portfolio Review
03:21pm, Monday, 09'th Mar 2026
The Silvant Large Cap Growth SMA returned +2.69% (gross)/+1.94% (net) for the quarter, outperforming the Russell 1000 Growth Index's return of +1.12%. Eli Lilly and Alphabet were among the top stock c
BMY Wins FDA Nod to Expand Sotyktu Label for Psoriatic Arthritis
01:05pm, Monday, 09'th Mar 2026
Bristol Myers wins FDA approval to expand Sotyktu for psoriatic arthritis after strong POETYK study data, adding a new indication for the TYK2 inhibitor.
Is Trending Stock Bristol Myers Squibb Company (BMY) a Buy Now?
10:00am, Monday, 09'th Mar 2026
Zacks.com users have recently been watching Bristol Myers (BMY) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
PRINCETON, N.J.--(BUSINESS WIRE)---- $BMY #CELMoD--Bristol Myers Squibb Announces Positive Phase 3 Data from the SUCCESSOR-2 Study of Oral Mezigdomide in Relapsed or Refractory Multiple Myeloma.
Bristol Myers Squibb Company (NYSE:BMY) Receives Consensus Rating of “Hold” from Brokerages
02:22am, Monday, 09'th Mar 2026
Shares of Bristol Myers Squibb Company (NYSE: BMY - Get Free Report) have been assigned a consensus rating of "Hold" from the twenty-two ratings firms that are covering the stock, MarketBeat reports.
Why Bristol Myers Squibb Stock Crushed it in February
07:47pm, Sunday, 08'th Mar 2026
The company's "growth portfolio" is offsetting declines in "legacy" treatments. It also showed marked progress in two of its developmental programs.
